Hyperlipoproteinemic Patients: A Case Study

. A research done by Illingworth, D.R. in 1990 shows that the management of the hyperlipoproteinemic patients were to reduce the levels of lipoproteins (fat deposit in arteries) so as to stop the bad effect of the hyperchylomicronemia in the subjects with high triglyceride levels. Diet was considered as the main therapy after excluding the secondary causes, but, decision whether to take drug therapy was and lipoproteins. The bile acid sequestrants mainly niacin and inhibitors of HMG CoA reductase like Lovastatin were mostly used for the person with high cholesterol levels. These agents lower levels of total and LDL Cholesterol by 15-45%. In those people who had high triglyceride levels coexist, Lovastatin, niacin and Simavastatin